Eptifibatide and low-dose tissue plasminogen activator in acute myocardial infarction: the integrilin and low-dose thrombolysis in acute myocardial infarction (INTRO AMI) trial. [electronic resource]
Producer: 20020306Description: 377-86 p. digitalISSN:- 0735-1097
- Adult
- Aged
- Coronary Vessels -- drug effects
- Dose-Response Relationship, Drug
- Drug Therapy, Combination
- Electrocardiography
- Eptifibatide
- Europe -- epidemiology
- Female
- Fibrinolytic Agents -- therapeutic use
- Humans
- Incidence
- Intracranial Hemorrhages -- chemically induced
- Male
- Middle Aged
- Myocardial Infarction -- complications
- North America -- epidemiology
- Peptides -- therapeutic use
- Platelet Aggregation Inhibitors -- therapeutic use
- Platelet Glycoprotein GPIIb-IIIa Complex -- antagonists & inhibitors
- Radiography
- South Africa -- epidemiology
- Survival Analysis
- Thrombocytopenia -- chemically induced
- Time Factors
- Tissue Plasminogen Activator -- therapeutic use
- Treatment Outcome
- Vascular Patency -- drug effects
No physical items for this record
Publication Type: Clinical Trial; Clinical Trial, Phase II; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.